Publications ESPOIR

1. Combe B. The french early arthritis register. Clinical and Experimental Rheumatology 2003,(suppl.31), S123-S129
   voir l'article : ESPOIR 1
   
   
2. Combe B, BenessianoJ, BerenbaumF, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X., Logeart I, Mariette X, Meyer O, Ravaud P, Rincheval N, Saraux A. , Schaeverbeke T. , Sibilia J. The ESPOIR cohort : a ten-year follow-up of early arthritis in France. Methodology and baseline characteristics of the 813 included patients.   Joint Bone Spine 2007 Oct;74(5):440-5. Epub 2007 Jul 26.
   voir l'article : ESPOIR 2
   
   
3. Devauchelle V, Josseaume T, Samjee I, Dougados M, Combe B, Saraux A. Ability of oblique foot radiographs to detect erosions in early arthritis: Results in the ESPOIR cohort. Arthritis Rheum. 2008;59:1729-34.
   voir l'article : ESPOIR 3
   
   
4. Lukas C, Guillemin F, Landewé R, van der Heijde D, Logeart I, Fautrel B ,Daures JP, Combe B. Factors determining a DMARD initiation in early arthritis patients. The ESPOIR cohort study. Clin Exp Rheumatol 2009; 27: 84-91
   voir l'article : ESPOIR 4
   
   
5. Benhamou M, Rincheval N, Roy C, Foltz V, Rozenberg S, Sibilia J, Schaeverbeke T, Bourgeois P, Ravaud P, Fautrel B. The Gap Between Practice and Guidelines in the Choice of First-line Disease Modifying Antirheumatic Drug in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort. J Rheumatol 2009; 36:5; doi:10.3899/jrheum.080762
   voir l'article : ESPOIR 5
   
   
6. Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X. Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis. Res Ther. 2009;11(4):R114.
   voir l'article : ESPOIR 6
   
   
7. Guennoc X, Narbonne V, Jousse-Joulin S, Devauchelle-Pensec V, Dougados M, Daurres JP, Saraux A. Is Screening for Hepatitis B and C Useful in Patients with Recent-Onset Polyarthritis?       Results of the ESPOIR cohort study.  J Rheumatol  2009 Jul;36(7):1407-13.
   voir l'article : ESPOIR 7
   
   
8. Funck-Brentano T, Etchepare F, Joulin SJ, Gandjbakch F, Pensec VD, Cyteval C, Miquel A, Benhamou M, Banal F, Le Loet X, Cantagrel A, Bourgeois P, Fautrel B. Benefits of ultrasonography in the management of early arthritis: a cross-sectional study of baseline data from the ESPOIR cohort. Rheumatology (Oxford). 2009 Dec;48(12):1515-9.
   voir l'article : ESPOIR 8
   
   
9. Fautrel B, Benhamou M, Foltz V, Rincheval N, Rat AC, Combe B, Berenbaum F, Bourgeois P, Guillemin F. Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort. Rheumatology (Oxford). 2010 Jan;49(1):147-55.
   voir l'article : ESPOIR 9
   
   
10. Salliot C, Bombardier C, Saraux A, Combe B, Dougados M. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort. Ann Rheum Dis. 2010 Apr 13. [Epub ahead of print] PubMed PMID: 19740903.
    voir l'article : ESPOIR 10
    
    
11. Cyteval C, Miquel A, Hoa D, Daures JP, Mariette X, Combe B. Rheumatoid Arthritis of the Hand: Monitoring with a Simplified MR Imaging Scoring Method--Preliminary Assessment. Radiology. 2010 ;256:863-9. Epub 2010 Jul 27.
    voir l'article : ESPOIR 11
    
    
12. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 Sep;69:1580-8 et Arthritis Rheum. 2010 ;62:2582-91.
    voir l'article : ESPOIR 12
    
    
13. Gossec L, Combescure C, Rincheval N, Saraux A, Combe B, Dougados M.Relative Clinical Influence of Clinical, Laboratory, and Radiological Investigations in EarlyArthritis on the Diagnosis of Rheumatoid Arthritis. Data from the French Early Arthritis  Cohort ESPOIR. J Rheumatol. 2010 Oct 15.
    voir l'abstract : ESPOIR 13
    voir l'article : ESPOIR 13
    
    
14. Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Patternotte S, Dougados D. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: Data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis 2011
    voir l'article : ESPOIR 14
    
    
15. Millot F, Clavel G et al. Musculoskeletal ultrasonography in healthy subjects andultrasound criteria for early arthritis (the ESPOIR cohort).  J Rheumatol 2011(in press)
    voir l'article : ESPOIR 15
    
    
16. Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM,Fardelone P,Bourgeois P,Fautrel B Comparison of the EQ-5D and the Short Form 6D utility measures in French patients with early arthritis: Results from the ESPOIR cohort. J Rheumatol 2011 Aug;38(8):1576-84. Epub 2011 May 1.
    voir l'article : ESPOIR 16
    
    
17. Lukas C, Combe B, Ravaud Ph, Sibilia J, Landewé R, van der Heijde D. Very early DMARD initiation in inflammatory arthritis is effective in inhibition of radiographic progression. Arthritis Rheumatism 2011 Jul;63(7):1804-11. doi: 10.1002/art.30371
    voir l'article : ESPOIR 17
    
    
18. Mouterde G , Lukas C, Logeart I, Flipo RM, Rincheval N, Daurès JP, Combe B Predictors of radiographic progression in the ESPOIR cohort. The season of first symptoms may influence the short-term outcome in early arthritis. Annals of Rheumatic Diseases 2011 Jul;70(7):1251-6. Epub 2011 Apr 22
    voir l'article : ESPOIR 18
    
    
19. Varache S, Narbonne V, Jousse-Joulin S, Guennoc X, Dougados M, Daurès JP, Devauchelle-Pensec V, Saraux A Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study. Arthritis Care Res (Hoboken). 2011 ;63:1565-70. doi: 10.1002/acr.20576
    voir l'article : ESPOIR 19
    
    
20. Salliot C, Dawidowicz K, Lukas C, Guedj M, Paccard C, Benessiano J, Dougados M, Nicaise P, Meyer O, Dieudé P.PTPN22 R620W genotype-phenotype correlation analysis and gene-environment interaction study in early rheumatoid arthritis: results from the ESPOIR cohort. Rheumatology (Oxford). 2011; 50 :1802-8. Epub ahead of print 2011 Jul 13
    voir l'article : ESPOIR 20
    
    
21. Fautrel B, Combe B, Rincheval N, Dougados M; for the ESPOIR Scientific Committee. Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data. Ann Rheum Dis. 2011 71:386-9. Epub 2011Oct 28.
    voir l'article : ESPOIR 21
    
    
22. Boyer JF, Bongard V, Cantagrel A, Jamard B, Gottenberg JE, Mariette X, Davignon JL, Ferrières J, Ruidavets JB, Dallongeville J, Arveiler D, Cambon-Thomsen A, Constantin A. Link between traditional cardiovascular risk factors and inflammation in early arthritis patients.Arthritis Care Res (Hoboken). 2012 64:872-80. Epub 2012 Jan 24
    voir l'article : ESPOIR 22
    
    
23. Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B. Responsiveness of the EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort. Annals Rheum Dis. 2012 71:1478-83. Epub 2012 Mar 14
    voir l'article : ESPOIR 23
    
    
24. Rat AC, Pouchot J, Fautrel B, Boumier P, Goupille P, Guillemin F. Factors associated with fatigue in early arthritis: Results from the ESPOIR cohort. Arthritis Care Res (Hoboken). 2012 Feb 21. doi: 10.1002/acr.21647. [Epub ahead of print]
    voir l'article : ESPOIR 24
    
    
25. Escalas C, Dalichampt M, Combe B, Fautrel B, Guillemin F, Durieux P, Dougados M, Ravaud P. Effect of adherence to European treatment guidelines on early arthritis outcome Ann Rheum Dis. 2012 May 6. [Epub ahead of print]
    voir l'article : ESPOIR 25
    
    
26. Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, Saraux A, Roux-Lombard P, Mariette X. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 2012 71:1243-8. Epub 2012 Apr 24
    voir l'article : ESPOIR 26
    
    
27. Gaujoux-Viala C, Paternotte S, Combe B, Dougados M. Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its sub-optimal use: results from the ESPOIR early synovitis cohort. Rheumatology (Oxford). 2012 Jul 19. [Epub ahead of print]
    voir l'article : ESPOIR 27
    
    
28. Nicaise-Roland P, Nogueira L, Demattei C, de Chaisemartin L, Rincheval N, Cornillet M, Grootenboer-Mignot S, Dieudé P, Dougados M, Cantagrel A, Meyer O, Serre G, Chollet-Martin S. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort. Ann Rheum Dis. 2012 May 12. [Epub ahead of print]
    voir l'article : ESPOIR 28
    
    
29. Zhang B, Combe B, Rincheval N, Felson DT. Validation of ACR/EULAR Definition of Remission in Rheumatoid Arthritis from RA Practice: The ESPOIR cohort. Arthritis Research & Therapy 2012 29;14:R156. [Epub ahead of prin
    voir l'article : ESPOIR 29
    
    
30. Gaujoux-Viala C, Fautrel B, Guillemin F, Flipo RM, Bourgeois P, Rat AC. Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort.Rheumatology (Oxford). 2013 May;52(5):832-8. doi: 10.1093/rheumatology/kes270. Epub 2012 Oct 22
    voir l'article : ESPOIR 30
    
    
31. Fautrel B, Granger B, Combe B, Le Loet X on behalf of the ESPOIR Scientific Committee Risk model of rapid radiographic progression in early rheumatoid arthritis treated by methotrexate in the ESPOIR cohort Arthritis Research & Therapy 2012 19;14:R249. [Epub ahead of print]
    voir l'article : ESPOIR 31
    
    
32. Sellam J,Kotti S, Fellahi S, Bastard JP, Meyer M, Lioté F, Meyer O, Simon T, Capeau J, Berenbaum F. Serum hepcidin level is not an independent surrogate biomarker of disease activity or of radiographic progression in rheumatoid arthritis : results from ESPOIR cohort Ann Rheum Dis 2012Nov 12. [Epub ahead of print (letter)
    voir l'article : ESPOIR 32
    
    
33. Saraux A, Tobon GJ, Benhamou M, Devauchelle-Pensec V, Dougados M, Mariette X, Meyer O, Berenbaum F, Chiocchia G, Rat AC, Schaeverbecke Th, Rincheval N, Fautrel B, Combe B. Potential classification criteria for rheumatoid Arthritis after two years: Results from a French multicenter cohort. Arthritis Care Research 2013 Aug;65(8):1227-34. doi: 10.1002/acr.21982.
    voir l'article : ESPOIR 33
    
    
34. Castrejon I, Pincus T, Soubrier M, Chang Lin Y, Rat AC, Combe B ,Dougados M . GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate . Rheumatology (Oxford). 2013 Oct;52(10):1890-7. doi: 10.1093/rheumatology/ket230. Epub 2013 Jul 17
    voir l'article : ESPOIR 34
    
    
35. Funck-Brentano T,Grandjbakhch F,Etchepare F, Jousse-Joulin S, Miquel A,Cyteval C,Lukas C, Tobon G, Saraux A, Boumier P, Goupille P, Bourgeois P, Fautrel B. Sonographic erosions and power-Doppler signal predict radiographic damage in early arthritis : The ESPOIR ultrasonographiy longitudinal study. Arthritis Care & Research 2012 Dec 4. doi: 10.1002/acr.21912. [Epub ahead of print]
    voir l'article : ESPOIR 35
    
    
36. Castrejon I, Pincus T, Guillemin F, Fautrel B, Combe B ,Dougados M. Possible remission criteria in rheumatoid arthritis without a formal joint count, based on careful joint examination and self-report RAPID3 score : Data from the ESPOIR usual care cohort. J Rheumatol. 2013 Apr;40(4):386-93. doi: 10.3899/jrheum.121059. Epub 2013 Feb 1.
    voir l'article : ESPOIR 36
    
    
37. Le Boëdec M, Marhadour T, Devauchelle-Pensec V, Jousse-Joulin S, Binard A, Fautrel B, Flipo RM, Le Loët X, Ménard JF, Saraux A.Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany).Semin Arthritis Rheum. 2013 Apr;42(5):474-81. doi: 10.1016/j.semarthrit.2012.08.001. Epub 2013 Jan 24.
    voir l'article : ESPOIR 37
    
    
38. Knevel R, Lukas C, van der Heijde D, Rincheval N2,Combe B, van der Helm-van Mil A. Defining erosive disease typical of RA in the light of the ACR/EULAR 2010 criteria for Rheumatoid Arthritis; results of the data-driven phase. Annals of the Rheumatic Diseases 2013 Apr;72:590-5
    voir l'article : ESPOIR 38
    
    
39. van der Heijde D, H.M. van der Helm-van Mil A, Aletaha D, Bingham C, Burmester G, Dougados M, Emery P, Felson D, Knevel R, Kvien TK, Landewé R, Lukas C, McInnes I, Silman I, Smolen J, Stanislawska-Biernat E, Zink A, Combe B. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria. Annals of Rheumatic the Diseases 2013 ;72:479-81
    voir l'article : ESPOIR 39
    
    
40. Vesperini V, Lukas C, Fautrel B, Le Loet X,Rincheval N, Combe B Does cigarette smoking influence activity and severity in early rheumatoid arthritis? Results from the ESPOIR cohort. Arthritis Care Research 2013 Jul 8. doi: 10.1002/acr.22057. [Epub ahead of print]
    voir l'article : ESPOIR 40
    
    
41. Combe B , Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, Ravaud P, Saraux A, Schaeverbeke T, Sibilia J. Five-year favourable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. Journal of Rheumatology 2013 Oct;40(10):1650-7. doi: 10.3899/jrheum.121515. Epub 2013 Aug 15.
    voir l'article : ESPOIR 41
    
    
42. TobonG, Saraux A,Lukas C,Grandjbakhch F,Gottenberg JE, Mariette X, Combe B, Devauchelle-Pensec V. First-Year Radiographic Progression is the Best Predictor of Further Progression in Early Arthritis: Results of a Large National French Cohort. Arthritis Care Research 2013 Jul 16. doi: 10.1002/acr.22078. [Epub ahead of print]
    voir l'article : ESPOIR 42
    
    
43. Gossec L, Paternotte S, Combe B, Meyer O, Dougados M. Repeated anti-citrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis. Results from the ESPOIR cohort. J Rheumatol 2014 Jan;41(1):41-6. doi: 10.3899/jrheum.121313. Epub 2013 Nov 15.
    voir l'article : ESPOIR 43
    
    
44. Ruyssen-Witrand A, Lukas C, Nigon D, Dawidowicz K, Morel J, Sibilia J, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, Constantin A. Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts). Joint Bone Spine. 2013 Nov 4. pii: S1297-319X(13)00242-X. doi: 10.1016/j.jbspin.2013.10.002. [Epub ahead of print]
    voir l'article : ESPOIR 44
    
    
45. Combe B, Logeart I, Belkacemi M, Dadoun S, Schaeverbeke T, Daurès JP, Dougados M. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort. Ann Rheum Dis 2014 Jan 7. doi: 10.1136.
    voir l'article : ESPOIR 45
    
    
46. Meyer M, Sellam J, Fellahi S, Kotti S, Bastard JP, Meyer O, Lioté F, Simon T, Capeau J, Berenbaum F. Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res Ther. 2013 Dec 9;15(6):R210. [Epub ahead of print]
    voir l'article : ESPOIR 46
    
    
47. Dadoun S, Guillemin F, Lucier S, Looten V, Saraux A, Berenbaum F, Durand-Zaleski I, Chevreul K, Fautrel B. Work productivity loss in early arthritis during the first 3 years of disease. A study from the ESPOIR cohort. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1310-8. doi: 10.1002/acr.22298.
    voir l'article : ESPOIR 47
    
    
48. Gazal S1, Sacre K, Allanore Y, Teruel M, Goodall AH; (The CARDIOGENICS consortium), Tohma S, Alfredsson L, Okada Y, Xie G, Constantin A, Balsa A, Kawasaki A, Nicaise P, Amos C, Rodriguez-Rodriguez L, Chioccia G, Boileau C, Zhang J, Vittecoq O, Barnetche T, Gonzalez Gay MA, Furukawa H, Cantagrel A, Le Loët X, Sumida T, Hurtado-Nedelec M, Richez C, Chollet-Martin S, Schaeverbeke T, Combe B, Khoryati L, Coustet B, El-Benna J, Siminovitch K, Plenge R, Padyukov L, Martin J, Tsuchiya N, Dieudé P. . Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene Ann Rheum Dis. 2014 Jan 21. doi: 10.1136/annrheumdis-2013-204581. [Epub ahead of
    voir l'article : ESPOIR 48
    
    
49. Cornillet M, Ruyssen-Witrand A, Constantin A, Meyer O, Cantagrel A, Serre G, Nogueira L. 1.60 Autoantibodies to human citrullinated fibrinogen (AhFibA) and their subfamilies directed to the fibrin peptides α36-50Cit38,42 and β60-7460,72,74 are prognostic markers of radiographic damage in the very early arthritides of the French ESPOIR cohort. Ann Rheum Dis. 2014 Mar 1;73 Suppl 1:A26. doi: 10.1136/annrheumdis-2013-205124.59. 
    voir l'article : ESPOIR 49
    
    
50. Hmamouchi I,Combe B, Le Loet X, Fautrel B, Lukas C Prevalence, concordance and predictors of early and sustained remission assessed by various validated indices in the early arthritis "ESPOIR" cohort Joint Bone Spine 2014 Apr 1. pii: S1297-319X(14)00051-7. dos:
    voir l'article : ESPOIR 50
    
    
51. Mouterde G, Lukas C, Flipo RM, Goupille Ph, Rincheval N, Daurès JP, Combe B. ACPA, rheumatoid factor and differences in clinical presentation of early arthritis: results from the ESPOIR Cohort. J Rheumatol 2014 Aug;41(8):1614-22. doi: 10.3899/jrheum.130884. Epub 2014 Jul 15.
    voir l'article : ESPOIR 51
    
    
52. Bacconnier L, Rincheval, Flipo RM, Goupille P, Daures JP, Boulenger JP , Combe. B. Depression and anxiety risk in early rheumatoid arthritis: Results from the ESPOIR cohort. Rheumatology (Oxford). 2014 Sep 14. pii: keu371. [Epub ahead of print]
    voir l'article : ESPOIR 52
    
    
53. Chevreul K, Lucie S, Haour G, Harvard S, Laroche ML, Mariette X, Saraux A, Durand-Zaleski, I, Guillemin F, Fautrel. Evolution of direct costs in the first years of rheumatoid arthritis: Impact of early versus late biologic initiation. An economic analysis based on the ESPOIR cohort. PLoS One. 2014 May 8;9(5):e97077. doi: 10.1371/journal.pone.0097077. eCollection 2014
    voir l'article : ESPOIR 53
    
    
54. Ruyssen-Witrand A, Guernec G, Nigon D, Tobon G, Jamard B, Rat AC, Vittecoq O, Cantagrel A, Constantin A. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes. Ann Rheum Dis. 2014 May 2. doi: 10.1136/annrheumdis-2013-204906. [Epub ahead of print
    voir l'article : ESPOIR 54
    
    
55. Juge PA, van Steenbergen HW, Constantin A, Tobon GJ, Schaeverbeke T, Gazal S, Combe B, Devauchelle-Pensec V, Nigon D, van der Helm-van Mil AH, Dieude P.SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis.Ann Rheum Dis. 2014 Oct;73(10):1840-3. doi: 10.1136/annrheumdis-2014-205539. Epub 2014 Jun 16.
    voir l'article : ESPOIR 55
    
    
56. Toussirot E, Dumoulin G.Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort'- authors' reply. Arthritis Res Ther. 2014;16(2):407. Epub 2014 Apr 10.
    voir l'article : ESPOIR 56
    
    
57. Sellam J, Fellahi S, Bastard JP, Capeau J, Berenbaum F. Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort' - authors' reply.Arthritis Res Ther. 2014;16(2):408. Epub 2014 Apr 10
    voir l'article : ESPOIR 57
    
    
58. Combe B, Rincheval N.Early lessons from the recent-onset rheumatoid arthritis cohort ESPOIR. Joint Bone Spine. 2014 Sep 16. pii: S1297-319X(14)00184-5. doi: 10.1016/j.jbspin.2014.07.003. [Epub ahead of print]
    voir l'article : ESPOIR 58
    
    
59. Baillet A, Gossec L, Paternotte S, Combe B, Meyer O, Mariette X, Gottenberg JE, Dougados M. . Evaluation of serum IL-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: Results from the ESPOIR cohort. Arthritis Care Res (Hoboken). 2014 Nov 10. doi: 10.1002/acr.22513. [Epub ahead of print]
    voir l'article : ESPOIR 59
    
    
60. Combe B. ESPOIR and the French database management: what have we learned from the first years of follow-up? Clin Exp Rheumatol. 2014 Nov-Dec;32 Suppl 85(5):153-157. Epub 2014 Oct 30.  
    voir l'article : ESPOIR 60
    
    
61. Durán J, Combe B, Niu J, Rincheval N, Gaujoux-Viala C, Felson D. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort. Rheumatology 2015 Jul 14. pii: kev254. [Epub ahead of print] 
    voir l'article : ESPOIR 61
    
    
62. Van Nies JA, Tsonaka R, Gaujoux-Viala C, Fautrel B, van der Helm-van Mil AH. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts. Ann Rheum Dis. 2015 Jan 5. pii: annrheumdis-2014-206047. doi: 10.1136/annrheumdis-2014-206047. [Epub ahead of print]  
    voir l'article : ESPOIR 62
    
    
63. Seror R1, Le Gall-David S, Bonnaure-Mallet M, Schaeverbeke T, Cantagrel A, Minet J, Gottenberg JE, Chanson P, Ravaud P, Mariette X. Anti-Porphyromonas gingivalis antibodies titres are associated with non-smoking status in early rheumatoid arthritis: Results from the ESPOIR cohort. Arthritis Rheumatol. 2015 Mar 16. doi: 10.1002/art.39118. [Epub ahead of print]  
    voir l'article : ESPOIR 63
    
    
64. van Nies JA1, Alves C2, Radix-Bloemen AL3, Gaujoux-Viala C4, Huizinga TW5, Hazes JM6, Brouwer E7, Fautrel B8, Mil AH9 Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH. Arthritis Res Ther. 2015 Apr 23;17:108. doi: 10.1186/s13075-015-0616-3.  
    voir l'article : ESPOIR 64
    
    
65. Guellec D, Milin M, Cornec D, Tobon GJ, Marhadour T, Jousse-Joulin S, Chiocchia G, Vittecocq O, Devauchelle-Pensec V, Saraux A. Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort. RMD Open. 2015 Jul 15;1(1):e000070. doi: 10.1136/rmdopen-2015-000070. eCollection 2015.
    voir l'article : ESPOIR 65
    
    
66. Ana Maria Gherghe, Maxime Dougados, Bernard Combe, Robert Landewé, Carina Mihai, Francis Berenbaum, Ron Wolterbeek, Désirée van der Heijde. Common comorbidities in early arthritis and early spondyloarthritis, a comparative study - results from the ESPOIR and DESIR cohorts RMD Open. 2015 Sep 14;1(1):e000128. doi: 10.1136/rmdopen-2015-000128. eCollection 2015  
    voir l'article : ESPOIR 66
    
    
67. van Steenbergen HW, van Nies JA, Ruyssen-Witrand A, Huizinga TW, Cantagrel A, Berenbaum F, van der Helm-van Mil AH. IL2RA is associated with persistence of rheumatoid arthritis.Arthritis Res Ther. 2015 Sep 8;17:244. doi: 10.1186/s13075-015-0739-6  
    voir l'article : ESPOIR 67
    
    
68. Audo R, Daien C, Papon L, Lukas C, Vittecoq O, Hahne M, Combe B, Morel J. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res Ther. 2015 Jul 29;17:193. doi: 10.1186/s13075-015-0705-3.  
    voir l'article : ESPOIR 68
    
    
69. Duquenne C, Cornec D, Marhadour T, Jousse-Joulin S, Cantagrel A, Pavy S, Devauchelle-Pensec V, Saraux A. Lymphopenia in early arthritis: Impact on diagnosis and 3-year outcomes (ESPOIR cohort).Joint Bone Spine. 2015 Jul 13. pii: S1297-319X(15)00119-0. doi: 10.1016/j.jbspin.2015.02.012. [Epub ahead of print] 
    voir l'article : ESPOIR 69
    
    
70. Degboé Y, Constantin A, Nigon D, Tobon G, Cornillet M, Schaeverbeke T, Chiocchia G, Nicaise-Roland P, Nogueira L, Serre G, Cantagrel A, Ruyssen-Witrand A. Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort. RMD Open. 2015 Nov 26;1(1):e000180  
    voir l'article : ESPOIR 70
    
    
71. Miceli-Richard C, Taylor KE, Nititham J, Seror R, Nocturne G, Boudaoud S, Dieude P, Constantin A, Devauchelle-Pensec V, Tobón GJ, Mariette X, Criswell LA. Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression.Ann Rheum Dis. 2015 Jul;74(7):1480-1. doi: 10.1136/annrheumdis-2014-206530
    voir l'article : ESPOIR 71
    
    
72. Ruyssen-Witrand A, van Steenbergen HW, van Heemst J, Gourraud PA, Nigon D, Lukas C, Miceli-Richard C, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, van der Helm-van Mil AH, Constantin A. A new classification of HLA-DRB1 alleles based on acid-base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort).RMD Open. 2015 Nov 19;1(1):e000099
    voir l'article : ESPOIR 72
    
    
73. Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A, Chanson P, Gottenberg JE, Devauchelle-Pensec V, Tobón GJ, Mariette X, Miceli-Richard C. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort. Sci Rep. 2016 Jan 20;6:18421. doi: 10.1038/srep18421. PMID: 26785768 74) 
    voir l'article : ESPOIR 73
    
    
74. Guellec D, Narbonne V, Cornec D, Marhadour T, Varache S, Dougados M, Daurès JP, Jousse-Joulin S, Devauchelle-Pensec V, Saraux A. Diagnostic impact of routine Lyme serology in recent-onset arthritis: results from the ESPOIR cohort. RMD Open. 2016 Jan 11;2(1):e000120. doi: 10.1136/rmdopen-2015-000120. eCollection 2016.
    voir l'article : ESPOIR 74
    
    
75. Granger B, Combe B, Le Loet X, Saraux A, Guillemin F, Fautrel B. Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data. RMD Open. 2016;2(1):e000245. doi:10.1136/rmdopen-2016-000245.
    voir l'article : ESPOIR 75
    
    
76. Couderc M, Pereira B, Combe B, Devauchelle-Pensec V, Mariette X, Soubrier M. Comparison of modified disease-activity scores with original composite scores for prediction of structural damages in rheumatoid arthritis: Data from the ESPOIR cohort. doe:10.1016/j.jbspin.2015.12.009
    voir l'article : ESPOIR 76
    
    
77. Castrejón I, Dougados M, Combe B, Fautrel B, Guillemin F,  Pincus T. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions. The Journal of Rheumatology Apr 2016, jrheum.141586; DOI: 10.3899/jrheum.141586
    voir l'article : ESPOIR 77
    
    
78. Krams T, Ruyssen-Witrand A, Nigon D, Degboe Y, Tobon G, Fautrel B, Berenbaum F, Cantagrel A, Constantin A. Effect of age at rheumatoid arthritis onset on clinical, radiographic, and functional outcomes: The ESPOIR cohort, Volume 4865, Issue 5, 10/2016, Pages 471-613, ISSN 1297-319X, http://dx.doi.org/10.1016/j.jbspin.2015.09.010
    voir l'article : ESPOIR 78
    
    
79. Cornillet M, Ajana S, Ruyssen-Witrand A, Constantin A, Degboé Y, Cantagrel A, Meyer O, Serre G, Nogueira L; Autoantibodies to human citrullinated fibrinogen and their subfamilies to the α36-50Cit and β60-74Cit fibrin peptides similarly predict radiographic damages: a prospective study in the French ESPOIR cohort of very early arthritides. Rheumatology (Oxford) 2016; 55 (10): 1859-1870. doi: 10.1093/rheumatology/kew014
    voir l'article : ESPOIR 79
    
    
80. Che H, Combe B, Morel J, Cantagrel A, Gossec L, Lukas C. Performance of patient-reported outcomes in the assessment of rheumatoid arthritis disease activity:the experience of the ESPOIR cohort. Clin Exp Rheumatol. 2016 Jul-Aug; 34(4): 646–654. Published online 2016 Jun 22.
    voir l'article : ESPOIR 80
    
    
81. Ruyssen-Witrand A, Degboé Y, Cantagrel A, Nigon D, Lukas C, Scaramuzzino S, Allanore Y, Vittecoq O, Schaeverbeke T, Morel J, Sibilia J, Cambon-Thomsen A, Dieudé P, Constantin A. Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts. RMD Open. 2016;2(2):e000226. doi:10.1136/rmdopen-2015-000226.
    voir l'article : ESPOIR 81
    
    
82. Tournadre A, Pereira B, Dubost JJ, Rincheval N, Rat AC, Combe B, Soubrier M. Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up. Clin Exp Rheumatol. 2017 Mar-Apr;35(2):296-302. Epub 2017 Jan 4. PMID: 28079508
    voir l'article : ESPOIR 82
    
    
83. Durán J, Combe B, Niu J, Rincheval N, Gaujoux-Viala C, Felson DT.The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort. Rheumatology (Oxford). 2017 Apr 3. doi: 10.1093/rheumatology/kew472. [Epub ahead of print]
    voir l'article : ESPOIR 83
    
    
84. Roubille C, Rincheval N, Dougados M, Flipo RM, Daurès JP, Combe B. Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohort. Ann Rheum Dis. 2017 Feb 17. pii: annrheumdis-2016-210135. doi: 10.1136/annrheumdis-2016-210135. [Epub ahead of print] PMID: 28213564
    voir l'article : ESPOIR 84
    
    
85. Gandjbakhch F, Granger B, Freund R, Foltz V, Jousse-Joulin S, Devauchelle V, Afshar M, Albert JD, Bailly F, Constant E, Biale L, Milin M, Couderc M, Denarie D, Fradin A, Martaille V, Pierreisnard A, Poursac N, Saraux A, Fautrel B. Multireader assessment as an alternative to reference assessment to improve the detection of radiographic progression in a large longitudinal cohort of rheumatoid arthritis (ESPOIR). RMD Open. 2017 Jan 4;3(1):e000343. doi: 10.1136/rmdopen-2016-000343. eCollection 2017. PubMed PMID: 28123779; PubMed Central PMCID: PMC5237761.
    voir l'article : ESPOIR 85
    
    
86. Boeters DM, Gaujoux-Viala C, Constantin A, van der Helm-van Mil AHM. The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: results from the Leiden-EAC and ESPOIR cohorts.Semin Arthritis Rheum. 2017 Oct;47(2):170-174. doi: 10.1016/j.semarthrit.2017.04.009. Epub 2017 Apr 29
    voir l'article : ESPOIR 86
    
    
87. Boeters DM, Mangnus L, Ajeganova S, Lindqvist E, Svensson B, Toes REM, Trouw LA, Huizinga TWJ, Berenbaum F, Morel J, Rantapää-Dahlqvist S, van der Helm-van Mil AHM. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical.Arthritis Res Ther. 2017 May 31;19(1):115. doi: 10.1186/s13075-017-1324-y
    voir l'article : ESPOIR 87
    
    
88. Gaujoux-Viala C, Rincheval N, Dougados M, Combe B, Fautrel B. Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort. Ann Rheum Dis. 2017 Sep 2. pii: annrheumdis-2017-211268. doi: 10.1136/annrheumdis-2017-211268. [Epub ahead of print]
    voir l'article : ESPOIR 88
    
    
89. Truchetet ME, Dublanc S, Barnetche T, Vittecoq O, Mariette X, Richez C, Blanco P, Mahler M, Contin-Bordes C, Schaeverbeke T; FHU ACRONIM. Anti-carbamylated protein antibodies presence in early arthritis with a poorer clinical and radiological outcome: data from the French ESPOIR cohort.Arthritis Rheumatol. 2017 Aug 29. doi: 10.1002/art.40237. [Epub ahead of print]
    voir l'article : ESPOIR 89
    
    
90. Daien CI, Sellam J, Rincheval N, Fautrel B, Saraux A, Morel J, Berenbaum F, Daures JP, Combe B. Diabetes at the time of rheumatoid arthritis diagnosis is an independent predictor of pejorative outcomes: data from the early arthritis ESPOIR cohort. Joint Bone Spine. 2018 Feb 23. pii: S1297-319X(18)30041-1. doi: 10.1016/j.jbspin.2018.02.004.
    voir l'article : ESPOIR 90
    
    
91. Gossec L, Kirwan JR, de Wit M, Balanescu A, Gaujoux-Viala C, Guillemin F, Rat AC, Saraux A, Fautrel B, Kvien TK, Dougados M; RAID investigators. Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.Clin Rheumatol. 2018 Feb 21. doi: 10.1007/s10067-018-3998-1.
    voir l'article : ESPOIR 91
    
    
92. Sageloli F, Quesada JL, Fautrel B, Salliot C, Gaudin P, Baillet A. Moderate alcohol consumption is associated with increased radiological progression in women, but not in men, with early rheumatoid arthritis: results from the ESPOIR cohort (Étude et Suivi des Polyarthrites Indifférenciées Récentes).Scand J Rheumatol. 2018 May 18:1-7. doi: 10.1080/03009742.2018.1437216. [Epub ahead of print]
    voir l'article : ESPOIR 92
    
    
93. Louveau B, De Rycke Y, Lafourcade A, Saraux A, Guillemin F, Tubach F, Fautrel B, Hajage D. Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort. Rheumatology (Oxford). 2018 May 22. doi: 10.1093/rheumatology/key122.
    voir l'article : ESPOIR 93
    
    
94. Chevreau M, Paclet MH, Romand X, Quesada JL, Vittecoq O, Dieudé P, Toussaint B, Gaudin P, Baillet A.Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on 'Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis' by Jonsson et al. Ann Rheum Dis. 2018 Jan 10. pii: annrheumdis-2017-212816. doi: 10.1136/annrheumdis-2017-212816
    voir l'article : ESPOIR 94
    
    
95. Quistrebert J, Hässler S, Bachelet D, Mbogning C, Musters A, Tak PP, Wijbrandts CA, Herenius M, Bergstra SA, Akdemir G, Johannesson M, Combe B, Fautrel B, Chollet-Martin S, Gleizes A, Donnellan N, Deisenhammer F, Davidson J, Hincelin-Mery A, Dönnes P, Fogdell-Hahn A, De Vries N, Huizinga T, Abugessaisa I, Saevarsdottir S, Hacein-Bey-Abina S, Pallardy M, Broët P, Mariette X; ABIRISK Consortium. Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis. Semin Arthritis Rheum. 2018 Oct 12. pii: S0049-0172(18)30176-8. doi: 10.1016/j.semarthrit.2018.10.006.
    voir l'article : ESPOIR 95
    
    
96. Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L. Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain. Arthritis Res Ther. 2019 Feb 19;21(1):63. doi: 10.1186/s13075-019-1841-y.
    voir l'article : ESPOIR 96
    
    
97. Mouasni S, Gonzalez V, Schmitt A, Bennana E, Guillonneau F, Mistou S, Avouac J, Ea HK, Devauchelle V, Gottenberg JE, Chiocchia G, Tourneur L. The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding. Cell Death Dis. 2019 Feb 25;10(3):190. doi: 10.1038/s41419-019-1412-9.
    voir l'article : ESPOIR 97
    
    
98. Mouterde G, Rincheval R , Lukas C, Daien C, Saraux A, Dieudé Ph, Morel J, Combe B. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort. Arthritis Res Ther 2019 on line first
    voir l'article : ESPOIR 98
    
    
99. Mariette X, Perrodeau E, Verner C, Struillou X, Picard N, Schaeverbeke T, Constantin A, Ravaud P, Bouchard P.Role of good oral hygiene on clinical evolution of rheumatoid arthritis: A randomized study nested in the ESPOIR cohort ; Rheumatology (Oxford). 2019 Sep 3. pii: kez368. doi: 10.1093/rheumatology/kez368. [Epub ahead of print]
    voir l'article : ESPOIR 99
    
    
100. Bernardy C, Lejeune S, Courtier A, Wendling D, Berenbaum F, Nguyen MVC, Gaudin P, Paclet MH, Baillet A.Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: analysis of the ESPOIR cohort. Joint Bone Spine. 2019 Jul 17. pii: S1297-319X(19)30106-X. doi: 10.1016/j.jbspin.2019.07.001. [Epub ahead of print]
     voir l'article : ESPOIR 100
     
     
101. Carvajal-Alegria G, Milin M, Gandjbakhch F, Saraux A, Bailly F, Jousse-Joulin S, Schaeverbeke T, Lukas C, Foltz V, Fautrel B, Devauchelle-Pensec V. A Simplified Radiographic Score Effectively Predicts Radiographic Progression of Early Arthritis in a Large Nationwide French Cohort; Rheumatology (Oxford). 2019 Oct 19. pii: kez450. doi: 10.1093/rheumatology/kez450. [Epub ahead of print]
     voir l'article : ESPOIR 101
     
     
102. Lukas C, Mary J, Debandt M, Daïen C, Morel J, Cantagrel A, Fautrel B, Combe B. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort. Arthritis Research & Therapy 2019 (in press)
     voir l'article : ESPOIR 102
     
     
103. Hillion J, Bellier A, Romand X, Fautrel B, Mariette X, Sagéloli F, Baillet A, Gaudin P. Alcohol is not the missing link between Porphyromonas gingivalis-related periodontitis and radiological progression in early rheumatoid arthritis: comment on 'Porphyromonas gingivalis experimentally induces periodontitis and an anti-CCP2-associated arthritis in the rat'. Ann Rheum Dis. 2019 Jun 14. pii: annrheumdis-2019-215603. doi: 10.1136/annrheumdis-2019-215603. [Epub ahead of print]
     voir l'article : ESPOIR 103
     
     
104. Vanier A, Smolen JS, Allaart CF, Vollenhoven RV, Verschueren P, Vastesaeger N, Saevarsdottir S, Visser K, Aletaha D, Combe B, FautrelB. An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases. Rheumatology (Oxford). 2019 Nov 13. pii: kez542. doi: 10.1093/rheumatology/kez542.
     voir l'article : ESPOIR 104
     
     
105. Mouterde G, Gamon E , Rincheval N, Lukas C, Seror R, Berenbaum F, Dupuy AM, Daien C, Daurès JP, Combe B. Association between Vitamin D deficiency and disease activity, disability and radiographic progression in early rheumatoid arthritis. J Rheumatol 2019 Dec 15. pii: jrheum.190795. doi: 10.3899/jrheum.190795.
     voir l'article : ESPOIR 105
     
     
106. Rauwel B, Degboé Y, Nigon D, Boyer JF, Abravanel F, Izopet J, Combe B, Ruyssen-Witrand A, Constantin A, Cantagrel A, Davignon JL. Reduced Progression of Bone erosion in Cytomegalovirus Seropositive Rheumatoid Arthritis Patients. Arthritis Res Ther. 2020 Jan 20;22(1):13. doi: 10.1186/s13075-020-2098-1
     voir l'article : ESPOIR 106
     
     
107. Guellec D, Cozien S, Ruyssen-Witrand A, Dieudé P, Saraux A. Prevalence and clinical significance of extra-articular manifestations at diagnosis in the ESPOIRcohort with recent-onset arthritis.Semin Arthritis Rheum. 2020 Jan 27. pii: S0049-0172(20)30004-4. doi: 10.1016/j.semarthrit.2020.01.004
     voir l'article : ESPOIR 107
     
     
108. Ferreira RJO, Fautrel B, Saraux A, Gaujoux-Viala C, Rat AC, Guillemin F, da Silva JAP, Dougados M, Gossec L. Patient global assessment and radiographic progression in early arthritis: 3-year results from the ESPOIR cohort. Arthritis Care Res (Hoboken). 2020 Apr 27. doi: 10.1002/acr.24237
     voir l'article : ESPOIR 108
     
     
109. Rodríguez-Muguruza S, Combe B, Guillemin F, Fautrel B, Olive A, Marsal S, Valero O, Rincheval N, Lukas C.Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: a longitudinal observational study, data from the ESPOIR cohort.Scand J Rheumatol. 2020 Apr 30:1-8. doi: 10.1080/03009742.2020.1726449
     voir l'article : ESPOIR 109
     
     
110. Niemantsverdriet E , Dougados M, Combe B , H M van der Helm-van Mil A. Referring early arthritis patients within 6 weeks versus 12 weeks after symptom onset: an observational cohort study. Lancet Rheumatol 2020 Published Online April 28, 2020 https://doi.org/10.1016
     voir l'article : ESPOIR 110
     
     
111. Valdeyron C, Soubrier M, Pereira B, Constantin A, Morel J, Gaudin P , Combe B, Gremeau AS, Dejou-Bouillet L, Pouly JL, Sapin V, Oris C, Brugnon F Impact of disease activity and treatments on ovarian reserve measured by serum AMH level in patients with early rheumatoid arthritis: A 36 months evaluation in the ESPOIR cohort . Rheumatology (Oxford). 2020 Nov 4:keaa535. doi: 10.1093
     voir l'article : ESPOIR 111
     
     
112. Kedra J, Granger B, Emilie S, Gaujoux-Viala C, Rat AC, Combe B, Fautrel B. Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIR. Joint Bone Spine. 2020 Aug 2:S1297-319X(20)30145-7. doi: 10.1016
     voir l'article : ESPOIR 112
     
     
113. Mathieu S, Pereira B, Saraux A, Richez C, Combe B, Soubrier M, Disease-modifying drug retention rate according to patient age in patients with early Rheumatoid arthritis: analysis of the ESPOIR cohort. Rheumatology International 2020 (in press)
     voir l'article : ESPOIR 113
     
     
114. Roubille C, MD, Coffy A, Rincheval N, Dougados M, PhD, Flipo RM, Daurès JP, Combe B. Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early Rheumatoid Arthritis. Rheumatology (Oxford). 2020 (in press)
     voir l'article : ESPOIR 114
     
     
115. Combe B, Rincheval N, Berenbaum F, Boumier P, Cantagrel A, Dieude P, Dougados M, Fautrel B, Flipo RM, Goupille P, Mariette X, Saraux A, Schaeverbeke T, Sibilia J, Vittecoq O, Daurès JP. Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort.Rheumatology (Oxford). 2021 May 7:keab398. doi: 10.1093
     voir l'article : ESPOIR 115
     
     
116. Kumaradev S, Roux C , Sellam J, Perrot S , Pham T , Dugravot A , Molto A. Sociodemographic determinants in the evolution of pain in inflammatory rheumatic diseases: results from ESPOIR and DESIR cohorts. Rheumatology (Oxford) . 2021 Jul 16;keab562. doi: 10.1093/rheumatology/keab562. Online ahead of print.
     voir l'article : ESPOIR 116
     
     
117. Kedra J, Seror R, Dieudé P, Constantin A,Toussirot E, Kfoury, Masson C, Cornec D, Dubost J, Marguerie L, Ottaviani S, Grados F2, Belkhir R , Fain O13, Goupille P, Sordet S , Fautrel B, Philippe P, Piperno M, Combe B, Lambotte O, Richez C, Sellam J, Sené T, Denis G, Lequerre T, Lazure T, Mariette X, Nocturne G. Lymphoma complicating rheumatoid arthritis: results from a French case-control study. RMD Open. 2021. 2021 Sep;7(3):e001698.doi: 10.1136 PMID: 34470830
     voir l'article : ESPOIR 117
     
     
118. Rodríguez-Muguruza S, Combe B, Guillemin F, Fautrel B, Olive A, Marsal S, Valero O, Lukas C. Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohort. Clin Exp Rheumatol. 2021 Sep 21. Online ahead of print.
     voir l'article : ESPOIR 118
     
     
119. Beltai A, Combe B, Coffy A, Gaujoux-Viala C, Lukas C, Saraux A, Dougados M, Daures JP, Hua, Impact of multimorbidity on disease modifying anti-rheumatic drug therapy in early rheumatoid arthritis: data from the Espoir cohort. Joint Bone Spine 2021 Dec 11:105326. doi: 10.1016
     voir l'article : ESPOIR 119
     
     
120. Gwinnutt JM, Norton S, Hyrich KL, Lunt M, Combe B, Rincheval N, Ruyssen-Witrand A, Fautrel B, McWilliams DF, Walsh DA, Nikiphorou E, Kiely P, Young A, Chipping JR, MacGregor A, Verstappen SMM. Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis. Rheumatology (Oxford). 2022 Mar 11:keac137. doi: 10.1093/rheumatology/keac137.
     voir l'article : ESPOIR 120
     
     
121. Vittecoq O, Guillou C, Hardouin J, Gerard B, Berenbaum F, Constantin A, Rincheval N, Combe B, Lequerre T, Cosette P. Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination. Arthritis Res Ther. 2022 Mar 21;24(1):72. doi: 10.1186/s13075-022-02762-5.
     voir l'article : ESPOIR 121
     
     
122. Kedra J, Lafourcade A, Combe B, Dougados M, Hajage D, Fautrel B, Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort. RMD Open 2022
     voir l'article : ESPOIR 122
     
     
123. Juge PA, Granger B, Debray MP, Ebstein E, Louis-Sidney F, Kedra J, Doyle TJ, Borie R, Constantin A, Combe B, Flipo RM, Mariette X, Vittecoq O, Saraux A, Carvajal Alegria G, Sibilia J, Berenbaum F, Kannengiesser C, Boileau C, Sparks JA, Crestani B, Fautrel B, Dieudé P. A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2022 May 18. doi: 10.1002/art.42162
     voir l'article : ESPOIR 123
     
     
124. Kedra J, Seror R, Dieudé P, Constantin A, Toussirot E, Kfoury E, Masson C, Cornec D, Dubost JJ, Marguerie L, Ottaviani S, Grados F, Belkhir R, Fain O, Fautrel B, Philippe P, Piperno M, Combe B, Lambotte O, Richez C, Sellam J, Sené T, Denis G, Lequerre T, Lazure T, Mariette X, Nocturne G. Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma. Joint Bone Spine 2022 Apr 28;89(5):105390. doi: 10.1016/j.jbspin.2022.105390.
     voir l'article : ESPOIR 124
     
     
125. Guellec D, Carvajal-Alegria G, Daien C, Gossec L, Guillemin F,Berenbaum F,Constantin A, Dieude P, Dougados M,Flipo RM,Goupille P,Mariette X, Richez D, Vittecoq O, Combe B, Saraux A. Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort; Clin Exp Rheumatol 2022 Jul 21. doi: 10.55563/clinexprheumatol/bdcl06
     voir l'article : ESPOIR 125
     
     
126. Sigaux J, Bellicha A, Buscail C, Julia C, Flipo RM, Cantagrel A, Laporte F, Beal C, Boissier MC, Semerano Serum Fatty Acid Profiles Are Associated with Disease Activity in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort.L.Nutrients. 2022 Jul 19;14(14):2947. doi: 10.3390/nu14142947
     voir l'article : ESPOIR 126
     
     
127. Bouget V, Duquesne J, Hassler S, Cournède PH, Fautrel B, Guillemin F, Pallardy M, Broët P, Mariette X, Bitoun S. Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts. RMD Open. 2022 Aug;8(2):e002442. doi: 10.1136/rmdopen-2022-002442.
     voir l'article : ESPOIR 127
     
     
128. Duquesne J, Bouget V, Cournède PH, Fautrel B, Guillemin F, de Jong PHP, Heutz JW, Verstappen M, van der Helm-van Mil AHM, Mariette X, Bitoun S. Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis. Rheumatology (Oxford). 2022 Nov 23:keac645. doi: 10.1093/rheumatology/keac645.
     voir l'article : ESPOIR 128
     
     
129. Le Quellec A, Guyard T, Carvajal Alegria G, Ruyssen-Witrand A, Fautrel B, Flipo RM, Garrigues F, Saraux A. Prevalence and predictors of atlanto-axial subluxation in rheumatoid arthritis after 12-years' follow-up (ESPOIR Cohort).Rheumatology (Oxford). 2022 Nov 28:keac672. doi: 10.1093/rheumatology/keac672
     voir l'article : ESPOIR 129 / (Complément méthodologie)
     
     
130. Gwinnutt JM, Norton S, Hyrich KL, Lunt M, Combe B, Rincheval N, Ruyssen-Witrand A, Fautrel B, McWilliams DF, Walsh DA, Nikiphorou E, Kiely PDW, Young A, Chipping JR, MacGregor A, Verstappen SMM. Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2022 Aug 4. doi: 10.1002/acr.24996
     voir l'article : ESPOIR 130
     
     
131. Salinas CA, Louder A, Polinski J, Zhang TC, Bower H, Phillips S, Song Y, Rashidi E, Bosan R, Chang HC, Foster N, Gershenson B, Yamanaka H, Kishimoto M, Tanaka Y, Fischer P, Zhu B, Faries D, Mai X, Doherty BT, Grelaud A, Thurin NH, Askling J, Deberdt W; B023 Study Consortium. Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases. Rheumatol Ther. 2022 Nov 13:1-23. doi: 10.1007/s40744-022-00505-1.
     voir l'article : ESPOIR 131
     
     
132. Dupont A, Constantin A, Soubrier M, Rincheval N, Avouac J. DAS28-γGT for the prediction of major cardiovascular events in rheumatoid arthritis: results from the ESPOIR cohort. Rheumatology (Oxford). 2023 May 31:kead251. doi: 10.1093/rheumatology/kead251.
     voir l'article : ESPOIR 132
     
     
133. Sepriano A, van Dijk B, Ramiro S, van der Helm-van Mil A, Combe B, van Schaardenburg D, de Wit M, Kent A, Mateus E, Landewé R. Distinction and prognosis of early arthritis phenotypes: An analysis in three European cohorts. RMDOpen 2023 Nov;9(4):e003611. doi: 10.1136/rmdopen-2023-003611.
     voir l'article : ESPOIR 133
     
     
134. Ruyssen-Witrand A, Guernec G, Dupont J, Lapuyade D, Lioté F, Vittecoq O, Degboé Y, Constantin A. Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low disease activity. .Arthritis Res Ther. 2023 Oct 20;25(1):207. doi: 10.1186/s13075-023-03176-7
     voir l'article : ESPOIR 134
     
     
135. Kumaradev S, Roux C, Sellam J, Perrot S, Pham T, Moltó A, Dugravot A. Do subjective components of disease activity contribute to heterogeneity in opioid prescriptions in inflammatory rheumatic diseases? Results from ESPOIRand DESIR cohorts.Clin Exp Rheumatol. 2023 Nov 29. doi: 10.55563/clinexprheumatol/nq59pt
     voir l'article : ESPOIR 135
     
     
136. Moulin D, Millard M, Taïeb M, Michaudel C, Aucouturier A, Lefèvre A, Bermúdez-Humarán LG, Langella P, Sereme Y, Wanherdrick K, Gautam P, Mariette X, Dieudé P, Gottenberg JE, Jouzeau JY, Skurnik D, Emond P, Mulleman D, Sellam J, Sokol H. Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis. Ann Rheum Dis. 2023 Dec 1:ard-2023-224014. doi: 10.1136/ard-2023-224014.
     voir l'article : ESPOIR 136
     
     

Manuscrits soumis